Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021

1. Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021 Persistence Market Research Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021 Persistence Market Research 1

2. Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021 Persistence Market Research Released New Market Report on “Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021”. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The currently available technologies fail to cure postmenopausal osteoporosis completely and thus healthcare professionals prefer medicinal therapy for treatment of postmenopausal osteoporosis. Request Full TOC: http://www.persistencemarketresearch.com/toc/5882 Considering the relation of age in postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market. While high standards for approval of any new product to launch into the market, competition from the emerging alternative technologies and intense competition from generics are restraining growth of this market. Mergers and acquisitions taking place in the market is one of the major restraining force of postmenopausal osteoporosis therapeutics market. Based on the type of medicines used, postmenopausal osteoporosis therapeutics market is segmented as follows: • Bisphosphonates • Hormones • Strontium ranelate • Raloxifene • Denosumab • Others Persistence Market Research 2

3. Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021 Geographically, the global postmenopausal osteoporosis therapeutics market is segmented into: • North America • Europe • Asia Pacific • Rest of the World Currently, North America dominates the postmenopausal osteoporosis therapeutics market and is closely followed by Europe. Asia-Pacific is a lucrative regional market for such drugs considering factors such as increasing healthcare spending and improving healthcare infrastructure. Gradual; development of the medical tourism industry in the region is also expected to further spur the growth of postmenopausal osteoporosis therapeutics market in Asia-Pacific. Some of the major companies contributing to the global postmenopausal osteoporosis therapeutics market are Eli Lilly, Pfizer, Inc., F. Hoffman La Roche, Procter & Gamble and Merck. Buy Full Report: http://www.persistencemarketresearch.com/market-research/postmenopausal- osteoporosis-therapeutics-market.asp Key geographies evaluated in this report are: North America • U.S • Canada Europe • France, Germany, Italy, Spain, and the UK • Eastern Europe • CIS APAC • China • India • Japan Persistence Market Research 3

4. Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021 • Australia • Others Latin America • Argentina • Brazil • Others Key points covered in the report 1) Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2) The report covers geographic segmentation  North America  Europe  Asia   RoW 3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4) The report provides company profiles of some of the leading companies operating in the market 5) The report also provides porters five forces analysis of the market. Persistence Market Research 4

5. Postmenopausal Osteoporosis Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021 About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services At Persistence Market Research (PMR), we are in the business of accelerating your business. As a full-service market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability. PMR’s Services Go Beyond Gleaning Data: Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines. Facilitating Rapid and Informed Business Decisions PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by carefully balancing traditional and modern-day research methodologies. Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. Phone: +1-646-568-7751 USA/Canada Toll Free Number. 1-800-961-0353 E-mail: sales@persistencemarketresearch.com Web : http://www.persistencemarketresearch.com Persistence Market Research 5